K Terada, A Yoshizawa, X Liu, H Ito… - Modern Pathology: an …, 2023 - europepmc.org
Neoadjuvant therapies (NATs) are used for locally advanced non-small cell lung carcinomas (NSCLCs), whereby pathologists histologically evaluate the effect using resected …
K Terada, A Yoshizawa, X Liu, H Ito… - … pathology: an official … - pubmed.ncbi.nlm.nih.gov
Neoadjuvant therapies are used for locally advanced non-small cell lung carcinomas, whereby pathologists histologically evaluate the effect using resected specimens. Major …
K Terada, A Yoshizawa, X Liu, H Ito… - Modern …, 2023 - modernpathology.org
Neoadjuvant therapies are used for locally advanced non–small cell lung carcinomas, whereby pathologists histologically evaluate the effect using resected specimens. Major …
K Terada, A Yoshizawa, X Liu, H Ito… - Modern …, 2023 - modernpathology.org
Neoadjuvant therapies are used for locally advanced non–small cell lung carcinomas, whereby pathologists histologically evaluate the effect using resected specimens. Major …
K Terada, A Yoshizawa, X Liu, H Ito… - Modern …, 2023 - kyushu-u.elsevierpure.com
Neoadjuvant therapies are used for locally advanced non–small cell lung carcinomas, whereby pathologists histologically evaluate the effect using resected specimens. Major …